Investor Relations
By helping our clients to consistently outperform and build a strong foundation for the future, Cowen aims to deliver long-term value for our shareholders.
FINANCIALS
Explore our SEC filings, corporate governance information and other shareholder information. Take a moment to read our latest Annual Report.
QUICK LINKS
- Annual Report
- Quarterly earnings
- Latest news
- Stock chart update
- Historical price lookup
- Stockholder services
- Analyst Coverage
- Investor Presentations
- Subsidiary Financial Statements
Stay up to date
GET IN TOUCH
Cowen Investor inquiries will be routed to Steve Lasota, CFO
Stock Quote
COWN
Exchange NASDAQ (USD)
Price $38.59
Change -0.07 / -0.18%
Volume 541,442
Data as of 12/01/2022 4:00 PM UTC.
Minimum 15 minute delay.
News
Escient Pharmaceuticals Announces $120 Million Series C Financing
Read the article “Escient Pharmaceuticals Announces $120 Million Series C Financing”
Cowen Washington Research Group #2 in Institutional Investor All America Research Poll
Read the article “Cowen Washington Research Group #2 in Institutional Investor All America Research Poll”
Cowen Stockholders Approve Acquisition by TD Bank Group
Read the article “Cowen Stockholders Approve Acquisition by TD Bank Group”
